TW201113061A - Manually-driven intravenous injection medicine calculation system and method applying medicine kinetics model - Google Patents
Manually-driven intravenous injection medicine calculation system and method applying medicine kinetics model Download PDFInfo
- Publication number
- TW201113061A TW201113061A TW98133924A TW98133924A TW201113061A TW 201113061 A TW201113061 A TW 201113061A TW 98133924 A TW98133924 A TW 98133924A TW 98133924 A TW98133924 A TW 98133924A TW 201113061 A TW201113061 A TW 201113061A
- Authority
- TW
- Taiwan
- Prior art keywords
- concentration
- drug
- unit
- record
- peak
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract description 77
- 238000004364 calculation method Methods 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims abstract description 23
- 238000010253 intravenous injection Methods 0.000 title claims abstract description 4
- 229940079593 drug Drugs 0.000 claims abstract description 59
- 238000003860 storage Methods 0.000 claims abstract description 15
- 230000000694 effects Effects 0.000 claims abstract description 14
- 238000012545 processing Methods 0.000 claims abstract description 10
- 230000009471 action Effects 0.000 claims description 24
- 238000002347 injection Methods 0.000 claims description 12
- 239000007924 injection Substances 0.000 claims description 12
- 238000001990 intravenous administration Methods 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000002547 new drug Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 3
- 238000001647 drug administration Methods 0.000 claims 3
- 230000009474 immediate action Effects 0.000 claims 1
- 210000004243 sweat Anatomy 0.000 claims 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 206010002091 Anaesthesia Diseases 0.000 description 9
- 230000037005 anaesthesia Effects 0.000 description 9
- 238000010586 diagram Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 2
- 230000037323 metabolic rate Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
Description
201113061 六、發明說明: 【發明所屬之技術領域】 本發明一種應用藥物動力學模型的手推靜脈注射藥劑計 算系統及方法,係運用多腔室加作用部位的藥物動力學模型 計算病患作用部位之藥劑濃度,方便使用者控制投藥劑旦及 掌握藥劑反應時間。 u 里 【先前技術】 以麻醉工作為例,引導麻醉或短期鎮靜的過程中,常需要 推注靜脈麻醉藥物,雖然藥物動力學的模型已經發展—: 然而,卻沒有將之應用在手推藥物的產品,“:賴 臨床醫師的經驗,可能有所誤差。目前尚無任何方法可 藥物動力學模型與分析大量病患的資料所取得的模型參數 以可靠而便捷的方法來估算手推投藥之後在作用部位‘ ,度變化。這種方法使醫師可以精確控制手推投藥劑量y 麻醉鎮靜更安全,提升醫療品f,增進手術團隊工作效率。 應用藥物動力學的模型與資訊的既有產品係將之應用於 =幫浦之中,本系統則將之應用在重覆手推注射的情境,' 尤其適用引導麻醉,能快速而平穩的導人麻醉狀能。 由於既有!品需要設置針筒幫浦、連聯結〜管 :源等步驟始能啟動,若是用於引導麻“:置連、: 續過於繁複,難收時效。 m手 由此可見,上述習用物品仍有缺失,實非 而亟待加以改良。 疋σ之。又a十 本案發明人鑑於上述習用麻醉方法所街生的各項缺點 加以改良創新,並經過多年研究 ' -種應用藥物動力學模型的手二二=功研發完成本件 法。 的乎推靜脈注射藥劑計算系統及方 【發明内容】 201113061 本發明之主要目的即在於使手推靜脈注射藥劑能簡易、快 4而平穩的達到安全而有效的藥物濃度範圍。 、 本發明之次要目的即在於藉由使用者介面獲得選擇藥物 與樂物動力學模型、輸人病患基本資料、劑量設定與投藥士己 體藥物動力學的統計結果推算個體的作用部 可達成上述發明目的之-種應用藥物動力學模型的 2注射藥劑計算系統及方法,係透過—使用者介面提供藥 物與模型選擇、輸入病患基本資料(例如:性別、年齡、身'古' =重等)、劑量設定(配方濃度、每次投藥量)、及&到達= s不设定、編輯投藥記錄、㈣新增投藥 相關參數儲存於料單元中,再由處理單元將上述=上= 用藥物動力學模型計算出作用部位濃度的時間函數,^⑴Γ 部位1%,行?將於制者介面顯示單元中顯示目前作用 c降二e技樂總里、^峰值、到達Ce峰值的時間、201113061 VI. Description of the Invention: [Technical Field] The present invention relates to a system and method for calculating a hand-injected intravenous drug using a pharmacokinetic model, which uses a pharmacokinetic model of a multi-chamber plus action site to calculate a patient's site of action The concentration of the drug is convenient for the user to control the dosage of the drug and to master the reaction time of the drug. u [Previous technique] Taking anesthesia as an example, in the process of guiding anesthesia or short-term sedation, intravenous anesthesia is often needed, although the pharmacokinetic model has been developed - but it has not been applied to hand-pushing drugs. The product, ": the experience of the clinician may be subject to error. There is currently no method for pharmacokinetic models and analysis of the parameters of a large number of patients to obtain model parameters in a reliable and convenient way to estimate the push after administration At the site of action, the degree changes. This method allows the physician to precisely control the amount of hand-pushing y. Anesthesia is safer, safer, and improve the efficiency of the surgical team. Application of pharmacokinetic models and information to existing products. Apply it to the = pump, this system will be applied to the situation of repeated hand-push injection, 'especially suitable for guiding anesthesia, can quickly and smoothly guide the anesthesia. Because there is a need to set the needle Tube pump, even connection ~ tube: source and other steps can start, if it is used to guide the hemp ": set up,: continue to be too complicated, difficult to accept aging. M hands It can be seen that the above-mentioned items are still missing, which is urgent and needs to be improved.疋σ之之. In addition, the inventor of the present invention improved and innovated in view of the shortcomings of the above-mentioned conventional anesthesia methods, and after years of research, the application of the pharmacokinetic model was completed. [Invention] The main purpose of the present invention is to enable a hand-push intravenously to achieve a safe and effective drug concentration range that is simple, fast and smooth. The secondary purpose of the present invention is to derive the function of the individual by using the user interface to obtain the selected drug and the kinetic model of the music, the basic data of the patient, the dose setting, and the statistical results of the pharmacokinetics of the drug. A two-injection drug calculation system and method for applying the pharmacokinetic model to achieve the above object is to provide a drug and model selection through a user interface, and input basic information of a patient (eg, gender, age, body 'ancient' = Weight, etc., dose setting (formulation concentration, dose per dose), and & reach = s not set, edit the medication record, (4) the new drug-related parameters are stored in the material unit, and then the processing unit will = Calculate the time function of the concentration of the site of action using the pharmacokinetic model, ^(1) 1 1% of the site, OK? The current function c will be displayed in the manufacturer interface display unit, the time of the peak, the time of reaching the Ce peak,
Ce降至底限所需時間等人一 警示單元,I 十 時早疋及一音效與燈號 严料-生:#底限時,藉由文字、圖形顯示與音效、 用者藥劑濃度是否在使用者需求的安全且有 :二定者二_注藥劑’使用者可視臨床需求 示、與自動新増投華&^限/作Λ部位漢度到達峰值警 所需藥劑之目的。另H又;1,達到便捷有效的控制病患 投藥並記錄,或修改Λ使用者更可依據手術進行之狀況’ 眘料,4 一 e氐限專相關設定,或是修正病人基本 的。 文全且準確地掌握及提供適合病患的劑量之目 【實施方式] !Γ,圖—' 圖二及圖三所示,本發明包含: =單元2,该儲存單元2提供各項設定參數的儲存。 201113061 -選擇藥物與模型模組1〇,該選擇藥 多種藥物及藥物動力學模型供使用者選擇。、、且^供 基料設定模組11 ’提供使用者輸入病患基本 ^ *年齡、身尚、體重、性別(請參閱圖二所示餘 入結果將儲存於儲存單元2中。 ’ 1 一劑量設定模組12,提供传 數包括配方濃度與每次投藥量參數。劑量參 儲存於儲存單元2卜又樂心參閱圖—所示)w果將 自動新增投藥記錄設定模组丨3 以自動模式進行新妗< 一 忧用者3又疋疋否 中。⑽新增技樂讀,設定結果將儲存於儲存單元2 一&底限設定模組14, 之底限,設定結果將儲存於儲存作用部位_The time required for Ce to fall to the bottom limit, etc., one warning unit, I am 10 o'clock early and a sound effect and light number is strict - raw: ##, when text, graphic display and sound effect, user concentration is in use The safety of the demand is as follows: the second person's second _ injection of the drug 'users can see the clinical needs, and the automatic new 増 増 & & ^ ^ ^ ^ ^ ^ ^ 汉 汉 汉 汉 汉 汉 汉 汉 汉 汉 汉 汉 汉 汉 汉 到达 到达 到达 到达Another H; 1, to achieve convenient and effective control of the patient to administer and record, or modify the 更 user can be based on the condition of the surgery 'suggested, 4 氐 专 limit specific settings, or to correct the patient's basic. Fully and accurately grasp and provide the dosage suitable for the patient [Embodiment] Γ, Figure - 'Figure 2 and Figure 3, the present invention includes: = unit 2, the storage unit 2 provides various setting parameters Storage. 201113061 - Select drug and model module 1〇, the drug of choice A variety of drug and pharmacokinetic models for users to choose. , and the base setting module 11 'provides the user to input the patient's basic ^ * age, body, weight, gender (please refer to Figure 2, the remaining results will be stored in the storage unit 2. ' 1 The dose setting module 12 provides the transfer number including the formula concentration and the dosage amount of each dose. The dose parameter is stored in the storage unit 2, and the reference figure is shown in the figure--will automatically add the medication record setting module 丨3 The automatic mode is used for new 妗< (10) Added technical music reading, the setting result will be stored in the storage unit 2 & bottom limit setting module 14, the bottom limit, the setting result will be stored in the storage action part _
達到峰值警示設定模組15,提供❹者決定在Q 否經由音效與燈號警示單元6發出提示, 疋、,,口果將儲存於儲存單元2。 處理單兀3,依照應用藥物動力^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 的樂物動力學模型配合儲存 ^至加作用。Η立 即眭眩外皙π π 1〜呆A,晨度)的變化函數,並 單元/中加=的數據與圖形製作單^5輪出之圖形由顯示 一 Π,該顯示單元4可為任何-種顯示設備。 開始對處理單元3的計算結果後,即 計時的過程Μ干單/&底限到達時刻予以倒數計時, 月 4不早70 4與圖形製作單元5顯示。 一顯示單元4,接收盧理s 。 的倒”時過程:即時::::=結果與計時… 單元過5程接3的計算結果_ f 、,‘曰製作用部位(Ce)函數的曲線,與c 5 201113061 時間記參閱圖六所示即時顯示在顯示設備上。 一音效與燈號警示單元6,當叶 時’處理單元3會驅使音效與燈號警時:: 與燈號。 干几0發出警不聲響 一投藥記錄編輯單元7,直係各立从& α 出警示聲與燈號提示使用者投藥;:用元6發 :™-筆投藥記錄;萬-使= = 本早元刪除或修正投藥記錄。 用 如圖四所示’兹以三腔室加作用部位藥物動力 =說明之:當投藥記錄更新後處理單㈣會以、= 出作用部位濃度⑹)的變化函數,以便進—步算出G ^ 到f Ce峰值時間及(;6降至底限的時間,與即時的^值,以 下说明本發明推算的辦法: 首先根據群體藥物動力學的研究結果可以由病患參數例 別、身商、體重、年齡等數據推算各腔室的體積盥藥物 3速率常數、藥物代謝速率常數,當以手推注射投荜於靜 劑會由中㈣位(血聚㈣運送至快平衡部位(肌肉、 月⑹、k +衡部位(脂肪等胸、作用部位(例如腦 :物、代謝排泄部位(肝臟、腎臟等卜…义表示各腔 至之體積’而各腔室間的藥物交換速率常數分別為 :久从’藥物代謝速率常數為“、作用部位的清除率 *為U以及每次投藥| Ce才氏達峰值所需時間上限為 上述參數可以由群體藥物動力學的統計結果推算。 令A,心為下列多項式的三個解: + M31 + Mu + W21 + M|2)X 也 _^12 + h +1 + 〜)=〇 母經過一次手推藥劑後,Ce函數可表示為:The peak warning setting module 15 is reached, and the provider determines whether the prompt is issued by the sound effect and the light warning unit 6 in the Q, and the result will be stored in the storage unit 2. The treatment of single 兀3, according to the application of drug dynamics ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ music dynamics model with storage ^ to add effect. Η Immediately glare the external 皙 π π 1~ stay A, morning) change function, and the unit / medium plus = data and graphics production single ^ 5 rounds of the graphic by the display, the display unit 4 can be any - A display device. After the calculation result of the processing unit 3 is started, the timing of the process is counted down, and the arrival time of the bottom limit is counted down, and the month 4 is not displayed 70 4 with the graphic creation unit 5. A display unit 4 receives Lu Li s. The process of "down": Instant::::=Results and timing... The calculation result of the unit over 5 passes 3 _ f , , 'The curve of the production part (Ce) function, and c 5 201113061 Time note see Figure 6 The instant display is displayed on the display device. An audio effect and light warning unit 6, when the leaf is processed, the processing unit 3 will drive the sound effect and the light alarm:: and the light number. Unit 7, direct each slave & alpha warning sound and light signal prompts the user to administer drugs;: use yuan 6 hair: TM-pen medication record; 10,000-make = = this morning delete or correct the medication record. Figure 4 shows the drug dynamics of the three-chamber plus action site. = Description: When the dosing record is updated, the treatment order (4) will change the function of the concentration of the site (6) to calculate G ^ to f. Ce peak time and (; 6 time to the bottom limit, and the immediate value, the following illustrates the method of the invention: First, according to the results of the group pharmacokinetics can be from the patient parameters, body, weight, The age and other data to calculate the volume of each chamber, the drug 3 rate constant, The metabolic rate constant of the substance, when administered by hand push, is transferred from the middle (four) position (blood aggregation (four) to the fast-balanced part (muscle, month (6), k + balance (fat, etc. chest, action site (such as brain: The substance and metabolic excretion sites (the liver, the kidney, etc. represent the volume of each cavity to the volume) and the drug exchange rate constants between the chambers are: the long-term 'drug metabolic rate constant is ', the clearance rate of the action site* is U and each time the drug is administered | Ce's peak time is required. The above parameters can be calculated from the statistical results of population pharmacokinetics. Let A, the heart be the three solutions of the following polynomial: + M31 + Mu + W21 + M| 2) X also _^12 + h +1 + ~) = After the mother-in-law pushes the drug once, the Ce function can be expressed as:
Ce{t)= Bolus, x (Z[e~^ + + z^tl) + 201113061 其中ί丨=推注時刻,βθ/MS 1 =推注劑量, = keQ (灸21 _ 乂i)fei —Λ) K〇 ~K (^2 -^)^1 Ζ2 == - ^e0 (^21 "^-2X^31 ~^) ^eO ~ (^2 ~ Λ Χ^2 ~ ^ )^1 Ζ3 = - ke〇 (^21 ~ ^3X^31 ~^) ^eO ~ 之4 =~(WZ3) 由於濃度函數具有加成性’所以經過„次推注後,濃度函 數加成為:Ce{t)= Bolus, x (Z[e~^ + + z^tl) + 201113061 where 丨 丨 = moment of bolus, βθ/MS 1 = bolus dose, = keQ (moxibustion 21 _ 乂i) fei — Λ) K〇~K (^2 -^)^1 Ζ2 == - ^e0 (^21 "^-2X^31 ~^) ^eO ~ (^2 ~ Λ Χ^2 ~ ^ )^1 Ζ3 = - ke〇(^21 ~ ^3X^31 ~^) ^eO ~ 4 =~(WZ3) Since the concentration function has additiveity, the concentration function is added after the lapse of the bolus:
CeW = Σ β〇Η X (Z,功-° + z2e普+ z3e普,i) + z ;_1 4 ) 此處ί g ίη 因為βθ/MSi,ii皆屬已知(由投藥記錄而來),所以化簡為:CeW = Σ β〇Η X (Z, work-° + z2e + z3e, i) + z ;_1 4 ) where ί g ίη because βθ/MSi, ii are known (from the drug record) , so the simplification is:
Ce(i)=命,+ + 知,+ 心Ce(i)=life, + + know, + heart
Ce'(i) = - AjS3e~A3t - ke〇S4e~ke〇t 其中Ji,汐2,心,54為常實數,Ce,為Ce的導函數。Ce'(i) = - AjS3e~A3t - ke〇S4e~ke〇t where Ji, 汐2, heart, 54 is a constant real number, and Ce is a derivative of Ce.
接著用二分逼近法得出Ce峰值(Ma;cCe)與Ce峰值 Umax)。因為Ce,=0處Ce有峰值,峰值之左Ce’ >0,峰值 之右ce’<0 ’所以可以用二分逼近法得imax,其演算法如 下:left = now right = now + ί_ do while right-left >1 //若左右兩邊界相距超過i秒 mid =(left + right)/2 //則取中點檢驗之 if Ce,(mid) < 0 then // 若中點在 imax 之右 right = mid "則以中點為新的右邊界 else //若中點不在imax之右 left = mid "則以中點為新的左邊界 201113061 //重覆上列步驟直到左右兩邊界相距少於1秒 tmax = mid //則以最後一次的中點當成imax的趨近值Then, the Ce peak (Ma; cCe) and the Ce peak Umax) were obtained by a binary approximation method. Because Ce, where Ce has a peak at 0, the left of Ce' > 0, and the right of ce' < 0 ', the imax can be obtained by the binary approximation method. The algorithm is as follows: left = now right = now + ί_ Do while right-left >1 //If the left and right boundaries are more than i seconds apart mid = (left + right)/2 // then take the midpoint test if Ce, (mid) < 0 then // if the midpoint Right imax right = mid " then the midpoint is the new right border else // if the midpoint is not right imax left = mid " then the midpoint is the new left border 201113061 // repeat the steps above Until the left and right boundaries are less than 1 second apart tmax = mid // then the last midpoint is taken as the approach value of imax
MaxCe = Ce (tmax) // MaxCe 發生在 imax 接著用二分逼近法得出Ce降至底限的時刻,在這裡的例 子以24小時為上限,如果所需時間超過一天,演算法就傳回 24小時後的時刻當作Ce降至底限的時刻。其中,LSCe是使 用者自訂的Ce底限,可視臨床需要而調整,由於之後 Ce是遞減的所以用下列演算法可得到iiB : left = tmax "找 tmax 之後,Ce(e)=LBCe right = left + 24_hours do while right - left > 1 //若左右兩邊界相距超過1秒 mid = (left + right )/2 "則取中點檢蜂之 if O(mid) < ZJCe then // 若中點在 之右 right = mid "則以中點為新的右邊界 else //右_點不在b之右 left = mid "則以中點為新的左邊界 //重覆上列步驟直到左右兩邊界相距少於1秒 iiB = mid //則以最後一次的中點當成的趨近值 請同時參閱圖五及圖六所示’為本發明一種應用率物動力 學模型的手推靜脈注射藥劑計算方法的執行流程圖: 步驟一:系統接收選擇藥物與模型模組、病患基本資料設 定模組、劑量設定模組、自動新增投藥記錄設定模組、Ce底 限設定模組、Ce到達峰值警示設定模組之各項輸入與投藥記 錄編輯單元之投藥記錄資料501。 步驟二:儲存單元儲存各項設定參數502。 201113061 步驟三:處理單元蚪曾 與Q峰值(Mfl;cCe)、函數及其導函數的各項係數 間(一)503。 值時間〜降至底限時 ?、:驟等四數步驟三計算後之。⑴、投藥總量、、 〜αχ iLS等數據顯示於g 示單元504 β 不早疋或、經圖形製料元後顯示於顯 幻步Γ二:::翠元及圖形製作單元依據步驟四之數據£ ^與〜會以不同的達峰值警示設定模組,當到達MaxCe = Ce (tmax) // MaxCe occurs at imax and then uses the binary approximation method to find the time when Ce falls to the bottom limit. The example here is based on 24 hours. If the time is more than one day, the algorithm returns 24 The hour after the hour is taken as the moment when Ce falls to the bottom limit. Among them, LSCe is the user-defined Ce bottom limit, which can be adjusted according to clinical needs. Since Ce is decremented later, iiB can be obtained by the following algorithm: left = tmax " After tmax, Ce(e)=LBCe right = left + 24_hours do while right - left > 1 //If the left and right boundaries are more than 1 second apart mid = (left + right )/2 " then take the midpoint check bee if O(mid) < ZJCe then / / If the midpoint is right = mid " then the midpoint is the new right border else // the right _ point is not the right of b left = mid " then the midpoint is the new left border // repeat Steps until the left and right boundaries are less than 1 second apart iiB = mid // then the nearest midpoint is the approach value. Please refer to Figure 5 and Figure 6 for an application rate dynamics model of the present invention. Flow chart of the calculation method of the hand push intravenous medicament: Step 1: The system receives the selected medicine and model module, the patient basic data setting module, the dose setting module, the automatic new medication record setting module, and the Ce bottom setting. Module, Ce reach the peak warning setting module input and medication record Dosing of recording data editing unit 501. Step 2: The storage unit stores various setting parameters 502. 201113061 Step 3: The processing unit 蚪 has a relationship with the Q peak (Mfl; cCe), the function and its derivative function (1) 503. When the value time ~ falls to the bottom limit, ?, :, and so on, the fourth step is calculated. (1), the total amount of the drug, ~αχ iLS and other data are displayed in the g indicating unit 504 β is not early or after the graphic material element is displayed in the visual step 2::: Tsui Yuan and the graphic production unit according to step 4 Data £^ and ~ will set modules with different peak strikes when arriving
丰眺. 不聲與燈號通知使用者505。 乂驟六.若自動新增投筚〆 &降至底限(晴%),則自組設定為開啟,而且 使用者聽新增—筆投藥記錄。此模式下, _ ^ " 曰或看見燈號便隨之投藥,益需再& 樂記錄506;若自動新描机“ 眾.、、' 而冉輸入投 七。 a技樂s己錄設定為不新增,則進行步驟 結束鍵Si覆;使:―者步按:二束_ 形,”!使用者按下結束鍵為:斷“及顯不即時數據與圖 請參考圖六所示,為本發 推靜脈注射㈣mu 種應心物動力學模型的手 的示意圖/、上十异糸統及方法的圖形製作單^所輸出圖形 劑後,。首先破i 度底限嫩)。開始注射藥Feng Wei. Notify the user 505 with the sound and the light. Step 6. If the automatic new investment & drop to the bottom limit (% clear), the self-group is set to on, and the user listens to the new-pen medication record. In this mode, _ ^ " 曰 or see the light will be followed by the drug, and the need to re-record the music record 506; if the automatic new machine "public.,," and then enter the vote seven. If it is set to not add, then the step end key is overwritten; so that: ― step by step: two bundles _ shape, "! The user presses the end key: break" and the display data is not shown in the figure. Shown, for the hair injection of the hair (four) mu kind of psychodynamic model of the hands of the schematic /, the top ten different systems and methods of the graphics production of the single output of the graphic agent, first break the i-degree limit tender). Start injection
LfiCe之時門A , ’ 然後Ce會遞減,下降至 時間為〜1;使用者聽聞音效與燈號警示 樂,同時新增投藥記錄;接 右冉度杈 值2),抵達的Γ 到新的峰值…峰 _ 間為其後&下降至之時間為 如此反覆進行到使用者停止使用為止;圖形製作單元^ 201113061 不斷即時更新圖形,直到執行結束。 本系統可儲存於電腦可讀 並執行後,即可完成本發明。°己錄媒體,當電腦載入本程式 本系統也可整合於病床邊之 計算機、或麻醉記錄軟體之内,咨、麻醉機、行動裝置、 行後,即可完成本發明。 田述儀器載入本程式並執 本發明與其他習用技術相互 L應用藥物動力學之多腔室…更具備下列優點: 群體藥物動力學推論各_ ° 7部位藥動模型,依據 記錄推算已投藥量I時:用動=數 值與G到達峰值的時間降,度⑼值、Q峰 隨時顯示給使用者參考。降至底限所需時間,並 2·::Γ與燈號警示單元,當作用部位濃度降至心 =限會以铃聲與燈號警示之方式提醒使用者追加藥 提二、達c e峰值警示’提示何時達到預期藥效可以進 仃技樂的目的(例如開始手術)。 明 t列詳細說明係針對本發明之一可行實施例之且體說 ’惟该貫施例並非用以限制本發明之專利範圍,凡未 本發明技藝精神戶斤$ t4 f f φ 專利範圍; 實或變更’均應包含於本案之 α綜上所述,本案不但在技術思想上確屬創新,並能較習用 ,品增進上述多項功效,應已充分符合新穎性及進步性之法 定發明專利要件’妥依法提出申請’懇請貴局核准本件發 明專利申請案,以勵發明,至感德便。 χ 【圖式簡單說明】 射 圖一為本發明一種應用藥物動力學模型的手推靜脈注 201113061 藥劑計算系統及方法之架構圖; 圖二為本發明一種應用藥物動力學模型的手 藥劑計算系統及方法之使用者介面輸人模組示意圖;/十 圖三為本發明一種應用藥物動力學模型的^推靜 藥劑計算系統及方法之使用者介面顯示單元示意圖,rw主射 圖四為本發明一種應用藥物動力學模型的 藥劑計算系統及方法之藥物動力學之三腔室 ^注射 模型; 用。p位藥動 圖五本發明一種應用藥物動力學模型的手推 、 劑計算系統及方法之圖形製作單^之圖形示意圖;I注射藥 圖六為本發明一種應用藥物動力學模型的手1^及 藥劑計算系統及方法之系統步驟流程圖 靜脈注射 【主要元件符號說明】 10 選擇藥物與模型模組 11 病患基本資料設定模組 12 劑量設定模組 13 自動新增投藥記錄設定模組 14 Ce底限設定模組 15 Ce到達峰值警示設定模組 2 儲存單元 3 處理單元 31 計時單元 4 顯示單元 5 圖形製作單元 6 音效與燈號警示單元 7 投藥記錄編輯單元LfiCe time gate A, ' Then Ce will be decremented, down to the time of ~1; the user hears the sound and the light warning, and adds the medication record; the right 杈 杈 value 2), arrived Γ to the new The peak...peak_between and the time it falls to the time is repeated until the user stops using it; the graphic creation unit ^201113061 constantly updates the graphic until the execution ends. The system can be stored in a computer readable and executable to complete the present invention. ° Recorded media, when the computer is loaded into the program The system can also be integrated into the computer under the bed, or the anesthesia recording software, the consultation, anesthesia machine, mobile device, and the line can complete the present invention. Tian Shu Instrument is loaded into this program and implements the multi-chamber with the pharmacokinetics of the invention and other conventional technologies. It has the following advantages: Group pharmacokinetic inference of each _ ° 7 site drug model, based on the record calculation has been administered When the quantity is I: the time value of the movement value and the peak value of G is reached, and the degree (9) value and the Q peak are displayed to the user for reference at any time. The time required to fall to the bottom limit, and 2·::Γ and the light warning unit, when the concentration of the active part falls to the heart=limit, the user will be reminded to add the medicine to the peak of the ce by means of the ringing and the warning of the light. Warnings 'Prompt when to achieve the desired effect can enter the purpose of the skill (for example, start surgery). DETAILED DESCRIPTION OF THE INVENTION The detailed description of the present invention is directed to one of the possible embodiments of the present invention and is not intended to limit the scope of the invention, which is not the scope of the invention. Or the change 'should be included in the Al of the case. The case is not only innovative in terms of technical thinking, but also more customary, and the product enhances the above-mentioned multiple functions. It should fully comply with the statutory invention patent requirements of novelty and progress. 'Properly submit an application according to law', please ask your office to approve the application for this invention patent, in order to invent invention, to the sense of virtue. χ [Simple diagram of the diagram] Figure 1 is a structural diagram of a drug calculation system and method for a hand-pushing intravenous injection 201113061 using a pharmacokinetic model; Figure 2 is a hand-pharmaceutical calculation system using a pharmacokinetic model of the present invention. And a method for inputting a user interface of the user interface; / FIG. 3 is a schematic diagram of a user interface display unit of the system for calculating a static drug calculation system and method using the pharmacokinetic model, and the main image of the rw is the present invention. A three-chamber injection model for pharmacokinetics of a drug calculation system and method using a pharmacokinetic model; P-position pharmacokinetic map five. A schematic diagram of a graphical representation of a hand-pushing, agent-calculating system and method using a pharmacokinetic model; I-injecting drug Figure 6 is a hand of a pharmacokinetic model of the present invention. Flow chart of the system steps of the drug calculation system and method [Main component symbol description] 10 Select drug and model module 11 Patient basic data setting module 12 Dose setting module 13 Automatically add medication record setting module 14 Ce The bottom limit setting module 15 Ce reaches the peak warning setting module 2 The storage unit 3 The processing unit 31 The timing unit 4 The display unit 5 The graphic creation unit 6 The sound effect and the light warning unit 7 The medicine record editing unit
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW98133924A TWI381862B (en) | 2009-10-07 | 2009-10-07 | Method and method of hand - push intravenous injection of pharmacokinetic model |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW98133924A TWI381862B (en) | 2009-10-07 | 2009-10-07 | Method and method of hand - push intravenous injection of pharmacokinetic model |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201113061A true TW201113061A (en) | 2011-04-16 |
| TWI381862B TWI381862B (en) | 2013-01-11 |
Family
ID=44909476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW98133924A TWI381862B (en) | 2009-10-07 | 2009-10-07 | Method and method of hand - push intravenous injection of pharmacokinetic model |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI381862B (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE72524B1 (en) * | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
-
2009
- 2009-10-07 TW TW98133924A patent/TWI381862B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TWI381862B (en) | 2013-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230277767A1 (en) | Optimized bio-synchronous bioactive agent delivery system | |
| RU2471514C2 (en) | Self-injection system | |
| ES2293366T3 (en) | INTRAVENOUS DRUG SUPPLY SYSTEM CONTROLLED BY COMPUTER. | |
| US20100185182A1 (en) | User interface indicating fluid location for an implantable fluid delivery device | |
| US20250275717A1 (en) | Controlling operation of drug administration devices using surgical hubs | |
| Skyler et al. | Is there a place for insulin pump therapy in your practice? | |
| JP2010534494A5 (en) | ||
| JP2018534701A5 (en) | ||
| EP4229649A1 (en) | Patient monitoring using drug administration devices | |
| Paldus et al. | Insulin pumps in general practice | |
| JP2019048232A (en) | Patient treatment device specific configuration output | |
| CN117919545A (en) | A drip control method, system, device and storage medium for infusion therapy | |
| Jung et al. | Implementation of standardized dosing units for iv medications | |
| CN201847986U (en) | Automatic analgesia anesthesia apparatus | |
| TW201113061A (en) | Manually-driven intravenous injection medicine calculation system and method applying medicine kinetics model | |
| CN101862491B (en) | Painless automatic anesthesia apparatus | |
| KR20090032334A (en) | Chemotherapy Prescription System and Method | |
| Ruiz et al. | Propofol sedation in general dental practice: the first 100 patients | |
| Viglione et al. | Controlled Release Transdermal Patch | |
| Page | Should Doctors Be Penalized for Patient Outcomes? | |
| JP2005013542A (en) | Nursing support apparatus | |
| Arcebido et al. | Pharmacist-led discharge counseling on subcutaneous insulin use and administration | |
| Dodd | Assessing patient preference for two types of elastomeric infusion device | |
| Strudwick | How Can the Technology Acceptance Model Be Applied to Enhance Infusion Pump Use By Health Care Professionals? | |
| KR101871831B1 (en) | Injection kit and method for controlling the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |